Video

Why probiotic health claims rarely succeed at EFSA: evidence standards, study populations, and the challenge of live microorganisms

Ger T. Rijkers, University College Roosevelt, Netherlands, discusses the regulatory frame about probiotics in Europe.

Probiotics and public health: small interventions, billion-Euro stakes

Mike Holland, who has spent decades valuing the health and economic impacts of policy choices for the European Commission, the European Environment Agency and the OECD, discusses the economic impact…

Bacteriophages and Lactic acid bacteria: a hidden challenge for dairy and probiotic production and how to control it

Douwe Van Sinderen, professor of Molecular Microbiology at School of Microbiology & APC Microbiome Ireland, focuses on bacteriophages infecting lactic acid bacteria used in food and probiotic applications.

Enteric pathogens as active drivers of dysbiosis: lessons from Bacillus cereus and experimental models of the gut microbiota

Emilia Ghelardi, Professor of Microbiology and Molecular Microbiology at the University of Pisa, explains how pathogens can actively disrupt the integrity of the commensal community.

Reinforcing the gut barrier: how probiotics support intestinal integrity and immune health

Arthur Ouwehand, Technical Fellow at IFF Finland, discusses the components and vulnerabilities of the gut barrier and reviews how probiotics and related dietary interventions can support its structure and function.

Probiotics and prevention: the €10 billion question for Europe

New IPA Europe analysis puts hard numbers on how evidence-based probiotic use could cut healthcare costs and boost productivity across the EU.

Bifidobacterium longum subsp. infantis M-63: shaping early-life gut microbiota and immunity in healthy full-term infants

Akari Hiraku, researcher at Innovative Research Institute, Morinaga Milk Industry Co., presented clinical data on Bifidobacterium longum subsp. infantis M-63, a probiotic strain with a remarkable capacity to utilize HMOs.

Faecalibacterium prausnitzii: a microbiome-based candidate for IBD, C. diff and cancer

Philippe Langella, Research director at INRAE, talks about how F. prausnitzii could be a beneficial commensal.

Standardizing evidence on probiotics in acute gastroenteritis: why guidelines diverge and clinicians are confused

Yvan Vandenplas, Head of the Pediatric Hospital at the University Hospital Brussels, uses the example of probiotics in acute gastroenteritis to highlight how heterogeneous methodologies in evidence synthesis can lead…

Microbiota, immunity, and the environment: towards an integrated One Health approach

At the 13th Probiotics, Prebiotics and New Foods Congress, Silvia Turroni (University of Bologna) shares insights from the session “The Microbiome and One Health,” which explored how the microbiota bridges…

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top